AquaBounty Technologies, Inc. (AQB)
0.90
+0.05
(+5.70%)
USD |
NASDAQ |
Nov 13, 16:00
0.8999
0.00 (0.00%)
After-Hours: 19:59
AquaBounty Technologies EPS Diluted (Quarterly) : -0.2882 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2882 |
| June 30, 2026 | -0.3169 |
| March 31, 2026 | -0.2629 |
| December 31, 2025 | -3.646 |
| September 30, 2025 | -0.3561 |
| June 30, 2025 | -0.871 |
| March 31, 2025 | 0.1037 |
| September 30, 2024 | -0.8806 |
| June 30, 2024 | -13.08 |
| March 31, 2024 | -2.899 |
| December 31, 2023 | -2.190 |
| September 30, 2023 | -1.596 |
| June 30, 2023 | -1.825 |
| March 31, 2023 | -1.823 |
| December 31, 2022 | -1.707 |
| September 30, 2022 | -1.531 |
| June 30, 2022 | -1.558 |
| March 31, 2022 | -1.440 |
| December 31, 2021 | -1.709 |
| September 30, 2021 | -1.933 |
| June 30, 2021 | -1.473 |
| March 31, 2021 | -1.289 |
| December 31, 2020 | -2.60 |
| September 30, 2020 | -1.876 |
| Date | Value |
|---|---|
| June 30, 2020 | -2.196 |
| March 31, 2020 | -2.294 |
| December 31, 2019 | -3.160 |
| September 30, 2019 | -2.794 |
| June 30, 2019 | -3.779 |
| March 31, 2019 | -3.524 |
| December 31, 2018 | -6.00 |
| September 30, 2018 | -4.113 |
| June 30, 2018 | -4.40 |
| March 31, 2018 | -4.103 |
| December 31, 2017 | -6.00 |
| September 30, 2017 | -5.60 |
| June 30, 2017 | -4.80 |
| March 31, 2017 | -4.80 |
| December 31, 2016 | -270.00 |
| September 30, 2016 | -180.00 |
| June 30, 2016 | -180.00 |
| March 31, 2016 | -180.00 |
| December 31, 2015 | -360.00 |
| September 30, 2015 | -180.00 |
| December 31, 2014 | -180.00 |
| September 30, 2014 | -180.00 |
| June 30, 2014 | -360.00 |
| March 31, 2014 | -180.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Agenus, Inc. | 0.0183 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.175M |
| Total Expenses (Quarterly) | 1.175M |
| Enterprise Value | 4.575M |
| Earnings Yield | -501.5% |
| Normalized Earnings Yield | -527.37 |